These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15359800)

  • 1. [Epidemiology of hepatitis C in Japan].
    Yano K; Yatsuhashi H; Yano M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):241-7. PubMed ID: 15359800
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatitis C and drug use: epidemiology, screening, natural history and treatment].
    Lucidarme D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B112-20. PubMed ID: 12180278
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatitis C and alcohol].
    Perlemuter G
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B105-11. PubMed ID: 12180277
    [No Abstract]   [Full Text] [Related]  

  • 4. The epidemiology and control of hepatitis C infection.
    Gungabissoon U
    Nurs Times; 2003 Aug 5-11; 99(31):24-5. PubMed ID: 13677115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiviral therapy of hepatitis C].
    Erhardt A; Petry W; Ebel M; Jablonowski H; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Mar; 38(3):259-69. PubMed ID: 10768250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV genotype 5: epidemiology and spread of an uncommon genotype.
    Verbeeck J; Peigue-Lafeuille H; Ross RS; Abergel A; Nevens F; Van der Merwe S; Van Ranst M; Henquell C
    J Clin Virol; 2008 Feb; 41(2):170-1. PubMed ID: 18069057
    [No Abstract]   [Full Text] [Related]  

  • 7. Introduction: combination antiviral therapy in chronic hepatitis C.
    Sherlock S
    J Hepatol; 1995; 23 Suppl 2():1-2. PubMed ID: 8720285
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of hepatitis C virus genotype 4.
    Abdo AA; Lee SS
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1233-9. PubMed ID: 15482528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of recurrent hepatitis C].
    Berenguer M
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():63-7. PubMed ID: 11968347
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatitis C virus genotype 4: epidemiology and treatment].
    Castera L; Morice Y; Grando V; Bon C; Dény P; Roulot D
    Gastroenterol Clin Biol; 2003 Jun; 27(6-7):596-604. PubMed ID: 12910223
    [No Abstract]   [Full Text] [Related]  

  • 11. Should treatment of hepatitis C in HIV-seropositive and HIV-seronegative patients with hemophilia include induction doses of interferon?
    McGovern B; Bica I
    Clin Infect Dis; 2003 Aug; 37(3):463-4; author reply 464-5. PubMed ID: 12884180
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatitis C].
    Yano K; Yatsuhashi H; Yano M
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():241-4. PubMed ID: 12722221
    [No Abstract]   [Full Text] [Related]  

  • 13. Managing hepatitis C infection in HIV-positive patients.
    Craven DE; Nunes DP
    AIDS Clin Care; 2000 Sep; 12(9):71-5, 78. PubMed ID: 12170952
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
    Shiraha H; Iwasaki Y; Shiratori Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
    [No Abstract]   [Full Text] [Related]  

  • 15. [Natural course of hepatitis C in infants infected by their mothers].
    Miyoshi Y; Etani Y; Mushiake S; Ozono K; Tajiri H
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):279-82. PubMed ID: 15359807
    [No Abstract]   [Full Text] [Related]  

  • 16. Future studies of combination therapy for chronic hepatitis C: optimizing response rates for each hepatitis C population.
    Main J
    J Hepatol; 1995; 23 Suppl 2():32-5; discussion 35-6. PubMed ID: 8720292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical, virologic and pathologic features of asymptomatic hepatitis C virus carriers].
    Shindo M; Okuno T
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):376-80. PubMed ID: 15359825
    [No Abstract]   [Full Text] [Related]  

  • 18. Advisory panel: expand hepatitis therapy to HIV/AIDS patients.
    AIDS Policy Law; 2002 Jul; 17(12):2. PubMed ID: 12134793
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C.
    Fernández I; Ulloa E; Colina F; Abradelo M; Jiménez C; Gimeno A; Meneu JC; Lumbreras C; Solís-Herruzo JA; Moreno E
    Liver Transpl; 2009 Aug; 15(8):948-55. PubMed ID: 19642125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.